BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 26688040)

  • 21. Electrospinning of polymeric nanofibers for drug delivery applications.
    Hu X; Liu S; Zhou G; Huang Y; Xie Z; Jing X
    J Control Release; 2014 Jul; 185():12-21. PubMed ID: 24768792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrospun matrices for localized drug delivery: current technologies and selected biomedical applications.
    Meinel AJ; Germershaus O; Luhmann T; Merkle HP; Meinel L
    Eur J Pharm Biopharm; 2012 May; 81(1):1-13. PubMed ID: 22342778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation, characterization, and fate of inhaled drug nanoparticles.
    Zhang J; Wu L; Chan HK; Watanabe W
    Adv Drug Deliv Rev; 2011 May; 63(6):441-55. PubMed ID: 21118707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thixotropic property in pharmaceutical formulations.
    Lee CH; Moturi V; Lee Y
    J Control Release; 2009 Jun; 136(2):88-98. PubMed ID: 19250955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of dendrimers and drug-dendrimer conjugates for drug delivery.
    Najlah M; D'Emanuele A
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):756-67. PubMed ID: 17987527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral controlled release dosage forms. II. Glassy polymers in hydrophilic matrices.
    Veiga F; Salsa T; Pina ME
    Drug Dev Ind Pharm; 1998 Jan; 24(1):1-9. PubMed ID: 15605591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanosponges - a completely new nano-horizon: pharmaceutical applications and recent advances.
    Ahmed RZ; Patil G; Zaheer Z
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1263-72. PubMed ID: 22681585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug delivery from ordered mesoporous matrices.
    Manzano M; Colilla M; Vallet-RegĂ­ M
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1383-400. PubMed ID: 19941412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticles in drug delivery: past, present and future.
    Couvreur P
    Adv Drug Deliv Rev; 2013 Jan; 65(1):21-3. PubMed ID: 22580334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silicon-polymer hybrid materials for drug delivery.
    McInnes SJ; Voelcker NH
    Future Med Chem; 2009 Sep; 1(6):1051-74. PubMed ID: 21425994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesoporous silicon: a platform for the delivery of therapeutics.
    Prestidge CA; Barnes TJ; Lau CH; Barnett C; Loni A; Canham L
    Expert Opin Drug Deliv; 2007 Mar; 4(2):101-10. PubMed ID: 17335408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanostructure-mediated drug delivery.
    Hughes GA
    Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-ordered nanopore and nanotube platforms for drug delivery applications.
    Losic D; Simovic S
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1363-81. PubMed ID: 19860534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposomal drug delivery systems: from concept to clinical applications.
    Allen TM; Cullis PR
    Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanostructured porous silicon-polymer-based hybrids: from biosensing to drug delivery.
    Bonanno LM; Segal E
    Nanomedicine (Lond); 2011 Dec; 6(10):1755-70. PubMed ID: 22122584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nano-formulations of drugs: Recent developments, impact and challenges.
    Jeevanandam J; Chan YS; Danquah MK
    Biochimie; 2016; 128-129():99-112. PubMed ID: 27436182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals.
    Pasquali I; Bettini R; Giordano F
    Adv Drug Deliv Rev; 2008 Feb; 60(3):399-410. PubMed ID: 17964684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanocarriers for oral drug delivery.
    Zhang L; Wang S; Zhang M; Sun J
    J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical and chemical stability of drug nanoparticles.
    Wu L; Zhang J; Watanabe W
    Adv Drug Deliv Rev; 2011 May; 63(6):456-69. PubMed ID: 21315781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted drug delivery to mammalian mitochondria in living cells.
    Weissig V
    Expert Opin Drug Deliv; 2005 Jan; 2(1):89-102. PubMed ID: 16296737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.